Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial

被引：0
|
作者：
Pirker, R [1 ]
Krajnik, G [1 ]
MohnStaudner, A [1 ]
Marhold, F [1 ]
Malayeri, R [1 ]
Zochbauer, S [1 ]
Kummer, F [1 ]
Greil, R [1 ]
Huber, H [1 ]
机构：
[1] AKH,DEPT ONCOL,AUSTRIAN ASSOC STUDY LUNG CANC,A-1090 VIENNA,AUSTRIA
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1139 / 1139
页数：1
相关论文
共 50 条
  • [1] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [2] Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):: An AASLC phase II trial
    Krajnik, G
    Mohn-Staudner, A
    Thaler, J
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Malayeri, R
    Schäfer-Prokop, C
    Wein, W
    Huber, H
    Pirker, R
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (08) : 993 - 998
  • [3] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer: an AASLC phase II trial
    Krajnik, G
    Malayeri, R
    Thaler, J
    Mohn-Staudner, A
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Zoechbauer-Mueller, S
    Huber, H
    Pirker, R
    [J]. 17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 647 - 649
  • [4] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study
    Frasci, G
    Panza, N
    Comella, P
    Nicolella, GP
    Natale, M
    Pacilio, C
    Gravina, A
    Caputi, V
    Botti, G
    Comella, G
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (10) : 1045 - 1048
  • [6] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [7] Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC)
    Sommers, E
    Ramnath, N
    Robinson, L
    Nwogu, C
    Tan, D
    Sharma, A
    Cantor, A
    Chiappori, A
    Williams, C
    Bepler, G
    [J]. LUNG CANCER, 2005, 49 : S96 - S97
  • [8] Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
    Lilenbaum, RC
    Chen, CS
    Chidiac, T
    Schwarzenberger, PO
    Thant, M
    Versola, N
    Lane, SR
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (01) : 97 - 101
  • [9] Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer
    Masters, GA
    Hoffman, PC
    Hsieh, AL
    Drinkard, LC
    Mick, R
    Samuels, BL
    Guaspari, A
    Golomb, HM
    Vokes, EE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 884 - 892
  • [10] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Heather A. Wakelee
    Gary Middleton
    David Dunlop
    Rodryg Ramlau
    Natasha Leighl
    Desiree Hao
    Arturo Lopez-Anaya
    Petr Zatloukal
    Charlotte D. Jacobs
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 815 - 824
12345